InDevR Licenses FDA Influenza Antibodies
InDevR Licenses FDA Influenza Antibodies for VaxArray™ InDevR’s access to [...]
ISIRV Options IX for the Control of Influenza
InDevR participated in the recent ISIRV Options IX Conference. In addition to [...]
Dr. Rowlen Opinion Piece in Vaccine
InDevR CEO, Dr. Kathy Rowlen, has contributed an opinion piece [...]
Enhanced Flu Vaccine Potency Assay
InDevR Launches Enhanced Flu Vaccine Potency Assay for All Stages [...]
Flu-ToC (now VaxArray Influenza) Webinar
Did You Miss the Free Flu-ToC (now VaxArray Influenza) Webinar? - [...]
